Role of host and viral factors and genetic variation of IL28B on therapy outcome in patients with chronic hepatitis C genotype 1b from Serbia

Role of host and viral factors and genetic variation of IL28B on therapy outcome in patients with chronic hepatitis C genotype 1b from Serbia

Show other versions (1)

In hepatitis C virus (HCV) infection viral and host factors can influence therapy outcome to pegylated interferon/ribavirin (PEG-IFN/RBV) and progression of liver fibrosis. Although novel direct-acting antivirals (DAAs) show newly successful treatment of hepatitis C infection, the majority of patie...

Full description

Bibliographic Details
Main Authors:	Snežana Jovanović-Ćupić, Nina Petrović, Milena Krajnović, Maja Bundalo, Nikola Kokanov, Ana Božović, Gorana Stamenković
Format:	Article
Language:	English
Published:	University of Sarajevo, Institute for Genetic Engineering and Biotechnology 2019-06-01
Series:	Genetics & Applications
Subjects:	Hepatitis C virus (HCV) genotype 1b IL28B polymorphism response to therapy liver fibrosis
Online Access:	https://genapp.ba/editions/index.php/journal/article/view/44

Similar Items

Role of host and viral factors and genetic variation of IL28B on therapy outcome in patients with chronic hepatitis C genotype 1b from Serbia
by: Snežana Jovanović-Ćupić, et al.
Published: (2019-06-01)

Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia
by: Kokanov Nikola S., et al.
Published: (2023-01-01)

Response factors to pegylated interferon-alfa/ribavirin treatment in chronic hepatitis C patients genotype 1b
by: Jovanović-Ćupić Snežana, et al.
Published: (2014-01-01)

Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city
by: Muhannad Abdullah Alazzawy
Published: (2018-07-01)

Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
by: Tarciana Grandi, et al.
Published: (2013-02-01)

Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
by: Tarciana Grandi, et al.
Published: (2013-02-01)

Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
by: Ghada M. Salum, et al.
Published: (2020-09-01)

Polymorphism of Interleukin 28 and HCV: Implementation of a method
by: Alessandra Flaminio, et al.
Published: (2012-12-01)

Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis
by: Amira Youssef Shaala, et al.
Published: (2015-09-01)

Paradoxical expression of <it>IL-28B </it>mRNA in peripheral blood in human T-cell leukemia virus Type-1 mono-infection and co-infection with hepatitis C Virus
by: Kamihira Shimeru, et al.
Published: (2012-02-01)

Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients
by: Paul Alain Tagnouokam-Ngoupo, et al.
Published: (2019-08-01)

Complete genome sequences and phylogenetic analysis of Hepatitis B virus isolates from Serbia
by: Lazarević Ivana, et al.
Published: (2012-01-01)

Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin
by: Osamu Yokosuka, et al.
Published: (2012-08-01)

Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rsI2979860 polymorphism of the <it>IL28B </it>gene
by: Lutz P, et al.
Published: (2011-08-01)

IL28B gene polymorphisms in mono- and HIV-coinfected chronic hepatitis C patients
by: Bruna Cristina Bertol, et al.
Published: (2015-03-01)

Correlation between interleukin-28 gene polymorphism with interleukin-28 cytokine levels and viral genotypes among HCV patients in Yazd, Iran
by: Mansour Moghimi, et al.
Published: (2019-09-01)

Comparative performance evaluation of hepatitis C virus genotyping based on the 5' untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C
by: do Carmo Debur Maria, et al.
Published: (2011-10-01)

Investigation of Genotype Distribution in Hepatitis C Patients in Giresun Province
by: Serpil GENÇ, et al.
Published: (2020-12-01)

Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients
by: Magda Cristina Bernardino Castilho, et al.
Published: (2011-12-01)

5′ UTR and NS5B-based genotyping of hepatitis C virus in patients from Damietta governorate, Egypt
by: Radwa R. El-Tahan, et al.
Published: (2018-03-01)

IL28B POLYMORPHISM AS A PREDICTOR OF ANTIVIRAL RESPONSE IN CHRONIC HEPATITIS C GENOTYPE 3
by: Javed Iqbal Farooqi, et al.
Published: (2015-01-01)

RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin
by: Kokanov Nikola S., et al.
Published: (2022-01-01)

Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil
by: R.S.M. Alencar, et al.
Published: (2008-03-01)

Peripheral B cells as reservoirs for persistent HCV infection
by: Masahiko eIto, et al.
Published: (2011-08-01)

Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
by: Jiménez-Sousa María A, et al.
Published: (2013-01-01)

Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C
by: Yone-Han Mah, et al.
Published: (2016-11-01)

The role of single nucleotide polymorphisms of cytokine genes in viral infections
by: Ćupić Maja, et al.
Published: (2014-01-01)

Distribution of HCV genotypes among different exposure categories in Brazil
by: Oliveira M.L.A., et al.
Published: (1999-01-01)

Relationship between gene polymorphism of IL-28B and clinical, laboratory, virologic parameters in patients with chronic HCV-infection
by: K. V. Zhdanov, et al.
Published: (2014-12-01)

The association between interleukin-28B gene polymorphisms as a potential biomarker and the risk of chronic Periodontitis in an Iranian population
by: Zahra Heidari, et al.
Published: (2017-06-01)

Prevalenza dei genotipi di HCV nella Sicilia centro-meridionale
by: Liborio Bellomo, et al.
Published: (2003-03-01)

Interleukin-28B Polymorphisms Predict the Efficacy of Peginterferon Alpha in Patients With Chronic Hepatitis B: A Meta-Analysis
by: Sang-Yu Ying, et al.
Published: (2021-07-01)

Antiviral therapy: Inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the Viral Genome
by: Laura Trejo-Ávila;, et al.
Published: (2007-07-01)

Seroprevalence of Hepatitis B and C Genotypes Among Young Apparently Healthy Females of Karachi-Pakistan
by: Kazmi SU, et al.
Published: (2008-01-01)

Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype
by: Motomura Takashi, et al.
Published: (2012-11-01)

Hepatitis B in Pediatric Population: Observational Retrospective Study in Romania
by: Daniela Păcurar, et al.
Published: (2024-03-01)

<i>IL28B</i> Genetic Variations in Patients with Recurrent Herpes Simplex Keratitis
by: Savić Borivoje, et al.
Published: (2019-09-01)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019-08-01)

Impact of IL28B gene variants (rs12979860) in peg-IFN therapy against Chronic Hepatitis B Pakistani patients
by: Irfan Kalam, et al.
Published: (2018-11-01)

The Distribution of Hepatitis C Virus (HCV) Genotypes in 59 HCV Infected Patients: A Multicenter Study
by: Emine SÖNMEZ, et al.
Published: (1996-06-01)